Abstract:Background Leukemia, a heterogeneous clonal disorder of hematopoietic progenitor cells, presents a world-wide health problem, especially in childhood. F1F0 ATPase, an inner mitochondrial enzyme, is expressed on the plasma membrane of tumor cells, and its inhibition induces both anti-angiogenic and anti-tumorigenic activity. Methods Monoclonal Antibody (McAb) against ATPase was produced by polyethylene glycol-mediated fusions and screened by ELISA. Proliferation, cell cycle and apoptosis of cells were analyzed when the surface ATPase of cells was blockaded with McAb. Results We detected cell-membrane expression of the F1F0 ATPase β subunit on 0.1% to 56% of the 11 cell lines derived from leukemia, including acute myeloid leukemia (AML). We produced a monoclonal antibody, McAb7E10, which recognizes both the native and recombinant ATPase β subunit, with a dissociation constant (KD) of 3.26E –10 . We demonstrate that McAb7E10 binds to ATPase at the cell surface, where it is able to inhibit ATP synthesis. McAb7E10 significantly inhibited proliferation of AML cell lines in vitro : the relative inhibitory rates of 50 μg/mL McAb7E10 treated MV4-11and HL-60 cells were 69.6% and 81.9% respectively. Cell cycle analysis indicated that McAb7E10 significantly induced apoptosis in MV4-11 and HL-60 cells: the relative rates of apoptosis in 5, 10 and 50ug/mL McAb7E10 treated MV4-11 cells was 3.6 ± 0.83%, 8.4 ± 1.69% and 17.3 ± 2.56% compared to 1.5% ± 0.85% in mouse IgG treated cells (p < 0.01). The relative rate of apoptosis in 5, 10 and 50ug/mL McAb7E10 treated HL-60 cells was 5.5 ± 2.37%, 11.3 ± 3.62% and 19.9 ± 3.31% compared to 1.56% ± 0.97% in mouse IgG treated cells (p < 0.01). Annexin V staining demonstrated that the relative apoptotic rates in 50 μg/mL McAb7E10 treated MV4-11 and HL-60 cells were 50.5% ± 7.04% and 32.9% ± 4.52%, respectively, significantly higher than IgG control antibody treated cells were 21.9% ± 3.11% and 15.3% ± 3.95%, p < 0.01. Conclusions These findings indicate that ectopic expression of ATPase β subunit may be a tumor-associated antigen in hematological malignancies. The F1F0 ATPase β subunit provides a potential target for immunotherapy in AML and hematological malignancies.

Preparation and anti-tumor activity of mouse monoclonal antibody against human F1-F0 ATP synthase beta subunit

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Dual Functions of a Monoclonal Antibody Against Cell Surface F1F0 ATP Synthase on Both HUVEC and Tumor Cells1

Prokaryotic expression of ATP5B and preparation and identification of its monoclonal antibody

A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase

Effect of a Novel Inhibitory Mab Antibody Against Β-Subunit of F1F0 ATPase on HCC

[Preparation of Monoclonal Antibody Against Lung Cancer and Identification of Its Targeting Antigen].

Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines

Antitumor activity of a 5T4 targeting antibody drug conjugate with a novel payload derived from MMAF via C-Lock linker.

A Monoclonal Antibody (Mc178-Ab) Targeted to the Ecto-Atp Synthase Β-Subunit-induced Cell Apoptosis Via a Mechanism Involving the MAKase and Akt Pathways

Biological Characterisation and Application of Human MTH1 and Monoclonal Antibody Preparation

Preparation and Identification of Monoclonal Antibody Against Human Atg5

Construction and Characterization of a High-Affinity Humanized SM5-1 Monoclonal Antibody.

[Preparation and Application of Monoclonal Antibodies Against DR Region of Na+-K+-ATPase Α1 Subunit].

[Preparation, Epitope Analysis and Clinical Application of Monoclonal Antibodies Against Heart-Type Fatty Acid Binding Protein].

Monoclonal Antibody Preparation and Expression Profile Analysis of A Novel Hepatoma Associated Gene

Preparation of anti-human esophageal cancer invasion and metastasis functional monoclonal antibody

Human tumor xenografts in mouse as a model for evaluating therapeutic efficacy of monoclonal antibodies or antibody-drug conjugate targeting receptor tyrosine kinases.

Expression of 5T4 extracellular domain fusion protein and preparation of anti-5T4 monoclonal antibody with high affinity and internalization efficiency.

Proteomics-based generation and characterization of monoclonal antibodies against human liver mitochondrial proteins.

Expression,purification and preparation of monoclonal antibody of HCA518 protein